Investments lift Melitek to large profit

Melitiak in Nørre Alslev has had another strong year and can now present one of its best financial statements ever. The year's profit after tax amounts to 40.6 million kroner, up from 33.0 million the year before. The gross profit has also increased to 99.4 million kroner compared to 84.1 million the year before.

Director Kim Laursen, who also owns the company with his brother Jesper Laursen, is pleased with the progress. 

- We are very satisfied. It is in all areas the best or second-best financial statement we have delivered, he says.

Melitek has been experiencing strong growth for several years, including during corona, when the company grew significantly by supplying plastic granulate for PCR test equipment. Today, the granulate is still aimed at the medical industry and is used, among other things, for contact lenses, catheters, diagnostic agents, and products for diabetes treatment.

Investments have an effect 

According to the director, this year's result is closely linked to several years of investments in both operations and development. The factory on Hartvig Jensensvej has been continuously expanded, and the company has invested in a new production line, which can now also be seen in the earnings.

- We have invested a lot in product development, and we have invested in a new production line. We can see that on the bottom line now, says Kim Laursen, adding that the company will continue to expand both capacity and competencies.

Solid finances and larger dividends 

Melitek is also financially strong. Equity has grown to 224.5 million kroner from 200.1 million the previous year, and the solvency remains high at 77.7 percent. On this basis, the management proposes a dividend of 22 million kroner, compared to 18 million kroner last year.

- We believe in the company and will continue to invest in it. Not only in pipes and buildings, but also in our employees, says Kim Laursen.